KURA

KURA ONCOLOGY INC

KURA·50127T109·US·Common Stock·Healthcare - Biotechnology-13D/G

KURA (KURA ONCOLOGY INC) is held by 121 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($78.4M), STATE STREET CORP ($36.7M), VANGUARD CAPITAL MANAGEMENT LLC ($30.8M). Net institutional sentiment: Mixed.

121
Holders
(10 Elite)
$391.3M
Total Value
50% (118)
Consensus
59 buying - 59 selling
13F: Insider & Congress:
KURA

Smart Money Verdict

View all
Held by 121 funds
10 elite

Who's Trading

ActivistARArmistice Capital, LLC4.2%May 15, 2026
ActivistVAVanguard Capital Management5.0%Apr 30, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.7%Feb 9, 2026
InsiderLMLeoni MollieSell $31KJan 27, 2026
InsiderLMLeoni MollieSell $19KJan 27, 2026
InsiderLMLeoni MollieSell $8KJan 27, 2026
InsiderLMLeoni MollieSell $11KJan 27, 2026
InsiderBBBair Teresa BrophySell $35KJan 27, 2026
InsiderBBBair Teresa BrophySell $20KJan 27, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.6M(+7.0%)$78.4M0.0%+14.35%
32
Decreased
4.5M(-8.5%)$36.7M0.0%-28.68%
0
New
3.8M$30.8M0.0%+9.18%
40
Decreased
2.1M(-30.6%)$17.3M0.0%+2.12%
0
Increased
2M(+0.3%)$16.5M0.0%-41.00%
28
Increased
1.6M(+22.7%)$13.3M0.0%+15.11%
34
Decreased
1.6M(-13.6%)$12.9M0.0%+3.99%
0
Decreased
1.6M(-1.2%)$12.7M0.0%-9.30%
0
Decreased
1.4M(-22.0%)$11.7M0.0%+6.77%
0
Increased
1.4M(+32.3%)$11.6M0.0%-16.52%
36
New
1.2M$10M0.0%+9.18%
38
Increased
1.2M(+46.1%)$10M0.0%+5.56%
38
Decreased
1.2M(-16.3%)$9.5M0.0%-27.15%
0
Decreased
1M(-1.9%)$8.5M0.0%-6.11%
0
Increased
800,597(+29.4%)$6.5M0.0%+0.22%
34
Increased
756,273(+4.6%)$6.1M0.0%-38.69%
28
Decreased
690,817(-2.8%)$5.6M0.0%-41.45%
0
Increased
675,305(+43.1%)$5.5M0.0%-4.35%
36
Increased
663,350(+39.0%)$5.4M0.0%-9.39%
36
Decreased
602,231(-70.2%)$4.9M0.0%+9.48%
0

Showing 1-20 of 130

1 / 7
KURAKURAKURA ONCOLOGY INC

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used